Related Experiment Video
Updated: Jul 26, 2026

Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
Published on: January 17, 2015
Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library
D F Cardoso1, F Nato, P England
1Laboratorio de Immunopatologia, Instituto Butantan, Sao-Paulo, Brasil; Laboratoire d'Ingénierie des Anticorps; Unité de Biochimie cellulaire, Institut Pasteur, France.
Researchers developed human antibodies using phage display technology to neutralize crotoxin, a snake venom toxin. These antibodies offer potential for a less aggressive passive immune therapy against Crotalus durissus terrificus venom poisoning.
Area of Science:
- Immunology
- Biochemistry
- Pharmacology
Background:
- Snakebite envenomation, particularly from Crotalus durissus terrificus, poses a significant health threat.
- Crotoxin, the primary toxin in C. durissus terrificus venom, is a neurotoxin that causes paralysis by blocking neuromuscular transmission.
- Current treatments for snakebite envenomation can have adverse effects, necessitating the development of novel therapeutic strategies.
Purpose of the Study:
- To isolate and characterize human single-chain variable fragment (scFv) antibodies specific for crotoxin using combinatorial phage display.
- To evaluate the in vivo neutralizing activity and biological effects of these human anticrotoxin scFvs.
- To explore the potential of these scFvs as a novel therapeutic approach for C. durissus terrificus envenomation.
Main Methods:
- Utilized a naive human scFv library exceeding 10^10 clones for phage display selection.
- Screened for scFvs that bind specifically to crotoxin, the main toxic component of C. durissus terrificus venom.
- Assessed the biological and immunological effects of isolated anticrotoxin scFvs, including neutralization of toxicity, myotoxicity, and enzymatic activity.
Main Results:
- Successfully isolated three human anticrotoxin scFvs (scFv 1, scFv 6, and scFv 8) with in vivo neutralizing activity.
- Demonstrated that scFv 8 reduces crotoxin-induced myotoxicity, while scFv 1 alters its in vitro enzymatic activity.
- All three scFvs recognize a common region on the crotoxin complex, and exhibit significant amino acid homology.
Conclusions:
- Human anticrotoxin scFvs derived from a naive library show promise for passive immunotherapy against C. durissus terrificus venom.
- The distinct biological activities of the isolated scFvs suggest a multifaceted therapeutic potential.
- These findings pave the way for developing a new, potentially less aggressive, passive immune therapy for crotoxin poisoning.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020